{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:12:02Z","timestamp":1776348722586,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.rmed.2024.107744","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T19:39:30Z","timestamp":1721849970000},"page":"107744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4819-1024","authenticated-orcid":false,"given":"Anders","family":"Kjellberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Hassler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Al-Ezerjawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Bostr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Abdel-Halim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovisa","family":"Liwenborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Dora","family":"Jonasdottir-Nj\u00e5stad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergiu-Bogdan","family":"Catrina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-6181","authenticated-orcid":false,"given":"Kenny A.","family":"Rodriguez-Wallberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0840-9244","authenticated-orcid":false,"given":"Peter","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rmed.2024.107744_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: the first line of defense against SARS-CoV-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2024.107744_bib2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/21505594.2021.1898790","article-title":"Immune dysregulation and system pathology in COVID-19","volume":"12","author":"Jamal","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.rmed.2024.107744_bib3","series-title":"Therapeutics and COVID-19: Living Guideline","year":"2023"},{"issue":"8","key":"10.1016\/j.rmed.2024.107744_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Group","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.rmed.2024.107744_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22839","article-title":"Efficacy and safety of casirivimab-imdevimab combination on COVID-19 patients: a systematic review and meta-analysis randomized controlled trial","volume":"9","author":"Wicaksono","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.rmed.2024.107744_bib6","series-title":"WHO Coronavirus Disease (COVID-19) Dashboard [web Page]","year":"2023"},{"issue":"2","key":"10.1016\/j.rmed.2024.107744_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.22462\/04.06.2020.2","article-title":"Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports","volume":"47","author":"Guo","year":"2020","journal-title":"Undersea Hyperb. Med."},{"issue":"3","key":"10.1016\/j.rmed.2024.107744_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.22462\/03.07.2020.1","article-title":"Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls","volume":"47","author":"Gorenstein","year":"2020","journal-title":"Undersea Hyperb. Med."},{"issue":"1","key":"10.1016\/j.rmed.2024.107744_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40001-021-00570-2","article-title":"The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review","volume":"26","author":"Oliaei","year":"2021","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"10.1016\/j.rmed.2024.107744_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2478\/jccm-2022-0008","article-title":"Effective outcome of HBOT as an adjuvant therapy in patients diagnosed with COVID-19 in a tertiary care hospital \u2013 a preliminary study","volume":"8","author":"Palaniappan","year":"2022","journal-title":"The Journal of Critical Care Medicine"},{"key":"10.1016\/j.rmed.2024.107744_bib11","article-title":"Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial","author":"Cannellotto","year":"2021","journal-title":"Emerg. Med. J. : Eng. Manag. J."},{"key":"10.1016\/j.rmed.2024.107744_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107155","article-title":"Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure","volume":"209","author":"Keller","year":"2023","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2024.107744_bib13","article-title":"Hyperbaric oxygen therapy efficacy as an adjuvant for the systemic inflammation reduction in patients with SARS-CoV-2 infection","volume":"4","author":"Toledo-Orozco","year":"2022","journal-title":"J. Clin. Res."},{"issue":"1","key":"10.1016\/j.rmed.2024.107744_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jcm12010008","article-title":"Effectiveness of hyperbaric oxygen therapy in SARS-CoV-2 pneumonia: the primary results of a randomised clinical trial","volume":"12","author":"Siewiera","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.rmed.2024.107744_bib15","article-title":"Hyperbaric oxygen therapy for COVID-19 patients: a prospective","year":"2021","journal-title":"Randomized Controlled Trial [Internet]"},{"key":"10.1016\/j.rmed.2024.107744_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110224","article-title":"Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?","volume":"144","author":"Kjellberg","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"7","key":"10.1016\/j.rmed.2024.107744_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046738","article-title":"Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19","volume":"11","author":"Kjellberg","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.rmed.2024.107744_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/5584_2020_568","article-title":"The role of hyperbaric oxygen treatment for COVID-19: a review","volume":"1289","author":"Paganini","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.rmed.2024.107744_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.rmed.2024.107744_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12144850","article-title":"COVID-19-Induced acute respiratory distress syndrome treated with hyperbaric oxygen: interim safety report from a randomized clinical trial (COVID-19-HBO)","volume":"12","author":"Kjellberg","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.rmed.2024.107744_bib21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.202006-2157CP","article-title":"Why COVID-19 silent hypoxemia is baffling to physicians","volume":"202","author":"Tobin","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107744_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.12688\/wellcomeopenres.15821.1","article-title":"A living systematic review protocol for COVID-19 clinical trial registrations","volume":"5","author":"Maguire","year":"2020","journal-title":"Wellcome Open Res"},{"issue":"2","key":"10.1016\/j.rmed.2024.107744_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00803-2022","article-title":"Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline","volume":"60","author":"Roche","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.rmed.2024.107744_bib24","article-title":"A general Overview on the hyperbaric oxygen therapy: applications, mechanisms and translational opportunities","volume":"57","author":"Ortega","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"10.1016\/j.rmed.2024.107744_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081210","article-title":"The effects of hyperbaric oxygenation on oxidative stress, inflammation and angiogenesis","volume":"11","author":"De Wolde","year":"2021","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.rmed.2024.107744_bib26","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3390\/antiox12122043","article-title":"Comparing the blood response to hyperbaric oxygen with high-intensity interval training-A crossover study in healthy volunteers","volume":"12","author":"Kjellberg","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.rmed.2024.107744_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010082","article-title":"The normobaric oxygen paradox-hyperoxic hypoxic paradox: a novel expedient strategy in hematopoiesis clinical issues","volume":"24","author":"Salvagno","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.rmed.2024.107744_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5603\/IMH.2017.0008","article-title":"Safety of hyperbaric oxygen therapy in mechanically ventilated patients","volume":"68","author":"Bessereau","year":"2017","journal-title":"Int. Marit. Health"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124002191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124002191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T06:20:40Z","timestamp":1725171640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124002191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":28,"alternative-id":["S0954611124002191"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107744","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107744"}}